Lilly Xu
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
-
- Drug Transport and Resistance Mechanisms
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Drug-Induced Hepatotoxicity and Protection 2
- Cholinesterase and Neurodegenerative Diseases 1
- Oncology 3
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Donald L. Kaminski (2 shared papers)Albert P. Li (2 shared papers)Magang Shou (2 shared papers)Gary L. Skiles (2 shared papers)Mary F. Ruh (2 shared papers)Margaret Reith (1 shared paper)John Gorski (1 shared paper)Stephen D. Hall (1 shared paper)
- Journals
- Drug Metabolism and Disposition (2 papers)Chemico-Biological Interactions (2 papers)Nucleic Acids Research (1 paper)Biochemical Pharmacology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesRussiaChina
In The Last Decade
Lilly Xu
8 papers receiving 396 citations
Peers
Comparison fields: 5 of 67
- Pharmacology 223
- Oncology 134
- Infectious Diseases 65
- Cancer Research 48
- Health, Toxicology and Mutagenesis 45
Countries citing papers authored by Lilly Xu
This map shows the geographic impact of Lilly Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilly Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilly Xu more than expected).
Fields of papers citing papers by Lilly Xu
This network shows the impact of papers produced by Lilly Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilly Xu. The network helps show where Lilly Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lilly Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 131 | |
| 2 | 2008 | 103 | |
| 3 | 2000 | 77 | |
| 4 | 2009 | 67 | |
| 5 | 1997 | 20 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2024 | 3 |
About Lilly Xu
Lilly Xu is a scholar working on Pharmacology, Oncology, Molecular Biology, Cancer Research and Infectious Diseases, having authored 8 papers that have together received 428 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Epigenetics and DNA Methylation (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper), Mosquito-borne diseases and control (1 paper) and Infectious Encephalopathies and Encephalitis (1 paper). The work is most often cited by research in Pharmacology (223 citations), Oncology (134 citations), Infectious Diseases (65 citations), Cancer Research (48 citations) and Health, Toxicology and Mutagenesis (45 citations). Lilly Xu has collaborated with scholars based in United States, Russia and China. Frequent co-authors include Donald L. Kaminski, Albert P. Li, Magang Shou, Gary L. Skiles, Mary F. Ruh, Margaret Reith, John Gorski, Stephen D. Hall, Yang Xu and Kari M. Morrissey. Their work appears in journals such as Drug Metabolism and Disposition, Chemico-Biological Interactions, Nucleic Acids Research, Biochemical Pharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.